Show simple item record

dc.contributor.authorBjorner, Jakob B.
dc.contributor.authorGandek, Barbara
dc.contributor.authorCole, Jason
dc.contributor.authorKosinski, Mark
dc.contributor.authorWallenstein, Gene
dc.contributor.authorAnatchkova, Milena
dc.contributor.authorWare, John E. Jr.
dc.date2022-08-11T08:10:41.000
dc.date.accessioned2022-08-23T17:16:46Z
dc.date.available2022-08-23T17:16:46Z
dc.date.issued2006-12-01
dc.date.submitted2010-06-22
dc.identifier.citationBjorner, J. B., Gandek B., Cole, J. C., Kosinski, M., Wallenstein, G. V., Anatchkova, M., and Ware J.E., Jr. Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044). 2006.
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47475
dc.language.isoen_US
dc.subjectOutcome Assessment (Health Care)
dc.subjectProduct Labeling
dc.subjectResearch
dc.subjectHealth Care Sector
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleResponse to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)
dc.typeResponse or Comment
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1610&context=qhs_pp&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/611
dc.identifier.contextkey1367207
refterms.dateFOA2022-08-23T17:16:47Z
dc.identifier.submissionpathqhs_pp/611
dc.contributor.departmentDepartment of Quantitative Health Sciences


Files in this item

Thumbnail
Name:
Bjorner_response_to_the_FDA_20 ...
Size:
120.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record